NCT03770741View on ClinicalTrials.gov

Safeguarding the Brain of Our Smallest Infants Phase III

NACompletedINTERVENTIONAL
Enrollment

1,601

Participants

Timeline

Start Date

June 20, 2019

Primary Completion Date

December 16, 2021

Study Completion Date

December 16, 2021

Conditions
Infant, Extremely PrematureBrain InjuriesDeath, BrainDeath; Neonatal
Interventions
OTHER

Modify cardio-respiratory support to avoid cerebral hypoxia

modification of cardio-respiratory support based on an evidence-based treatment guideline

OTHER

Treatment as usual

Monitoring and treatment according to local guidelines and practice

Trial Locations (1)

2100

Rigshospitalet, Copenhagen

All Listed Sponsors
collaborator

Copenhagen Trial Unit, Center for Clinical Intervention Research

OTHER

collaborator

Elsass Foundation

OTHER

lead

Gorm Greisen

OTHER

NCT03770741 - Safeguarding the Brain of Our Smallest Infants Phase III | Biotech Hunter | Biotech Hunter